Bio-Techne (TECH) Retained Earnings (2009 - 2026)
Bio-Techne's quarterly Retained Earnings came in at $1.1 billion in Q1 2026, up 1495.69% year-on-year from $71.8 million in Q1 2025, and up 3.47% quarter-over-quarter from $1.1 billion in Q4 2025.
Bio-Techne has reported Retained Earnings for 18 years, with the latest figure at $1.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 1495.69% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 1495.69% YoY), and the FY2025 full-year result was $1.1 billion, down 19.56% from the prior year.
- Retained Earnings for Q1 2026 stood at $1.1 billion, up from $1.1 billion in the prior quarter.
- The five-year high for Retained Earnings was $1.3 billion in Q3 2024, with the low at -$91.8 million in Q3 2022.
- Average Retained Earnings over 5 years is $667.9 million, with a median of $1.1 billion recorded in 2025.
- Peak annual rise in Retained Earnings reached 2106.0% in 2024, while the deepest fall reached 106.79% in 2024.
- Tracing TECH's Retained Earnings over 5 years: stood at $1.2 billion in 2022, then rose by 5.12% to $1.3 billion in 2023, then plunged by 106.79% to -$85.6 million in 2024, then jumped by 1392.26% to $1.1 billion in 2025, then increased by 3.47% to $1.1 billion in 2026.
- The last three Retained Earnings figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 1.15 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Bn |
| Dec 31, 2025 | 1.11 Bn |
| Sep 30, 2025 | 1.08 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | -82.05 Mn |
| Dec 31, 2024 | -85.65 Mn |
| Sep 30, 2024 | 1.34 Bn |
| Jun 30, 2024 | 1.33 Bn |
| Mar 31, 2024 | -75.31 Mn |
| Dec 31, 2023 | 1.26 Bn |
| Sep 30, 2023 | -78.02 Mn |
| Jun 30, 2023 | -66.06 Mn |
| Mar 31, 2023 | 1.25 Bn |
| Dec 31, 2022 | 1.20 Bn |
| Sep 30, 2022 | -91.81 Mn |
| Jun 30, 2022 | -75.20 Mn |
| Mar 31, 2022 | 1.13 Bn |
| Dec 31, 2021 | 1.15 Bn |
| Sep 30, 2021 | -64.22 Mn |
| Jun 30, 2021 | -57.29 Mn |
| Mar 31, 2021 | 1.09 Bn |
| Dec 31, 2020 | -64.24 Mn |
| Sep 30, 2020 | -83.14 Mn |
| Jun 30, 2020 | 1.06 Bn |
| Mar 31, 2020 | -103.46 Mn |
| Dec 31, 2019 | -78.35 Mn |
| Sep 30, 2019 | 931.36 Mn |
| Jun 30, 2019 | -83.52 Mn |
| Mar 31, 2019 | -79.63 Mn |
| Dec 31, 2018 | 895.21 Mn |
| Sep 30, 2018 | -70.63 Mn |
| Jun 30, 2018 | -44.81 Mn |
| Mar 31, 2018 | -15.86 Mn |
| Dec 31, 2017 | -56.82 Mn |
| Sep 30, 2017 | 802.43 Mn |
| Jun 30, 2017 | 799.03 Mn |
| Mar 31, 2017 | 778.84 Mn |
| Dec 31, 2016 | 769.01 Mn |
| Sep 30, 2016 | -63.93 Mn |
| Jun 30, 2016 | 770.55 Mn |
| Mar 31, 2016 | -76.48 Mn |
| Dec 31, 2015 | -51.53 Mn |
| Sep 30, 2015 | 724.59 Mn |
| Jun 30, 2015 | 713.85 Mn |
| Mar 31, 2015 | 699.47 Mn |
| Dec 31, 2014 | 687.06 Mn |
| Sep 30, 2014 | -22.98 Mn |
| Jun 30, 2014 | 653.28 Mn |
| Mar 31, 2014 | 637.92 Mn |
| Dec 31, 2013 | 617.72 Mn |
| Sep 30, 2013 | 604.10 Mn |
| Jun 30, 2013 | 14.55 Mn |
| Mar 31, 2013 | 572.19 Mn |
| Dec 31, 2012 | 550.12 Mn |
| Sep 30, 2012 | 535.81 Mn |
| Jun 30, 2012 | 21.78 Mn |
| Mar 31, 2012 | 6.88 Mn |
| Dec 31, 2011 | 487.52 Mn |
| Sep 30, 2011 | -20.22 Mn |
| Jun 30, 2011 | -16.29 Mn |
| Mar 31, 2011 | -15.84 Mn |
| Dec 31, 2010 | 433.39 Mn |
| Sep 30, 2010 | -17.29 Mn |
| Jun 30, 2010 | -21.23 Mn |
| Jun 30, 2009 | -7.48 Mn |